Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Cancers|October 13, 2021
Correction: van Bruggen et al. Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma. <i>Cancers</i> 2020, <i>12</i>, 3837Jaco A C van Bruggen, Anne W J Martens, Sanne H Tonino, et al.Cancers|December 23, 2020
Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin LymphomaJaco A C van Bruggen, Anne W J Martens, Sanne H Tonino, et al.Biomedicines|May 25, 2017
Innate Lymphoid Cells in Tumor ImmunityJasper J P van Beek, Anne W J Martens, Ghaith Bakdash, et al.Proceedings of the National Academy of Sciences of the United States of America|April 29, 2020
Ligand-dependent downregulation of MR1 cell surface expressionMariolina Salio, Wael Awad, Natacha Veerapen, et al.Journal for Immunotherapy of Cancer|June 26, 2020
CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cellsAnne W J Martens, Susanne R Janssen, Ingrid A M Derks, et al.Leukemia|January 19, 2023
Chronic lymphocytic leukemia presence impairs antigen-specific CD8<sup>+</sup> T-cell responses through epigenetic reprogramming towards short-lived effectorsAnne W J Martens, Inga Kavazović, Mia Krapić, et al.European Journal of Immunology|October 24, 2020
Human CXCR5<sup>+</sup> PD-1<sup>+</sup> CD8 T cells in healthy individuals and patients with hematologic malignanciesTom Hofland, Anne W J Martens, Jaco A C van Bruggen, et al.Blood|May 12, 2019
Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8<sup>+</sup> T cells and impede CAR T-cell efficacyJaco A C van Bruggen, Anne W J Martens, Joseph A Fraietta, et al.Cancer Research Communications|March 6, 2023
Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell LymphomasAnne W J Martens, Joanne M Rietveld, Renate de Boer, et al.Pageof 1